# CE-Marked PRP Tubes: What Certification Does and Does Not Cover

- Canonical: https://www.hairtransplantsource.com/articles/ce-marked-prp-tubes-regulation
- Site: Hair Transplant Source (https://www.hairtransplantsource.com)
- Topic: Instruments & Suppliers
- Author: Dr. Burhan Terzioğlu
- Medically reviewed by: Dr. Burhan Terzioğlu (Hair Restoration Surgeon · Contributing Author)
- Published: 2026-08-10 · Updated: 2026-08-14
- License: educational content, not medical advice; do not republish without permission.

**Quick answer:** A CE mark on a PRP tube certifies that the device meets EU MDR safety and performance requirements for its stated intended purpose — nothing more. It does not authorise re-injection if the tube was certified for diagnostics, does not validate clinical claims, and does not replace national rules on blood handling. Verify certificate, class and intended purpose before buying.

Every distributor selling PRP consumables into aesthetic clinics leads with the same two words: CE certified. The claim sits on plain citrate tubes costing two euros and on branded kits costing eighty, attached to brochures that read identically, and a clinic operator comparing suppliers has no obvious way to tell the certificates apart. The confusion is profitable, which is why it persists. CE marked PRP tubes are not a product category sharing one approval; the mark is a conformity declaration tied to a single device, a single manufacturer and — decisively — a single stated intended purpose.

This article sets out what the mark certifies under the EU Medical Device Regulation, why intended purpose determines whether your use of a tube is covered at all, how to verify a certificate in four documents, and what the mark leaves entirely to you: clinical claims, national blood-handling rules and operator competence. Member states diverge and transition rules keep moving, so every specific below ends at the same door — verify with your notified body or national regulator.

## What CE marked PRP tubes actually certify

The CE mark is the manufacturer's declaration that a device meets the general safety and performance requirements of the Medical Device Regulation (EU 2017/745), which has applied since 26 May 2021 and replaced the old Medical Device Directive. PRP tube regulation changed materially in that transition: classification tightened, clinical-evidence expectations rose, and grandfathered paperwork began to age out. For devices above class I, the manufacturer's declaration must be verified by a notified body — an accredited third party whose four-digit identification number appears beside the mark. What results is narrower than buyers assume: the certificate covers the device described in its technical documentation, for the intended purpose written there, and nothing beyond it.

Three practical consequences follow. A CE mark with no number beside it signals self-certification, which should stop the purchase of any device whose output is injected back into a patient. Certificates expire — MDR certificates typically run for up to five years — so a document issued in 2019 proves history, not current status. And transition arrangements have kept legacy MDD certificates in circulation well past the regulation's application date, which is exactly the kind of detail to confirm with the notified body rather than with the distributor.

## Intended purpose decides everything

The commonest false belief in PRP purchasing is that a CE mark anywhere on the box covers whatever the clinic does with the tube. It does not, and the industry's recurring problem shows why: blood-collection tubes certified as in-vitro diagnostic devices — certified, that is, for taking blood out of a patient for laboratory analysis — have been sold widely into aesthetic practice for preparing PRP that is injected back in. Re-injection is a different intended purpose from diagnosis. A tube certified for one is not certified for the other, however good the glass and the citrate.

Using a diagnostics-certified tube to produce an injectable is use outside the certified purpose, and the liability moves in one direction: towards the practitioner and the clinic. Under MDR classification logic, devices intended to modify blood for re-administration sit in higher risk classes — commonly IIa or IIb, depending on mechanism and additives — with correspondingly heavier notified-body scrutiny. Which MDR class a given PRP tube actually holds is fixed in its technical documentation and certificate; it is not a question a distributor's brochure can settle, and the definitive answer comes from the notified body behind the paperwork.

## Reading a certificate in four documents

Device certification sounds like a legal specialism; verifying it is fifteen minutes of administration.

| Document | What it establishes | Red flag |
|---|---|---|
| Declaration of Conformity | The manufacturer formally claims MDR conformity for a named device, class and purpose | Class I self-declaration on a device whose output is re-injected |
| Notified body certificate | Independent verification; the four-digit number is checkable against the EU's NANDO database | Number absent from NANDO, expired dates, certificate naming a different product line |
| Instructions for use | The intended purpose in the manufacturer's own words | Wording limited to diagnostic use, or silent on re-injection |
| UDI / EUDAMED entry | Registration and traceability of the specific device | Device unfindable; distributor promises documents after purchase |

The IFU deserves the closest read. If the stated purpose does not describe preparation of platelet-rich plasma for autologous re-injection, the rest of the paperwork is decoration. Repeat the file check annually for each product — the same supplier-file discipline our [instruments guide](/articles/hair-transplant-instruments-guide) recommends across the whole surgical inventory.

## Class, additives and the price question

Price is the least reliable signal on this market. Plain 3.2% sodium-citrate tubes retail for a few euros each; gel-separator systems for ten to twenty; closed-system branded kits for fifty or more per treatment. All can hold perfectly legitimate certificates, and the class does not scale with the invoice — an expensive kit is not somehow more certified than a cheap tube. The premium buys separator chemistry, closed-system handling and brand, and those purchases should be argued on preparation quality: platelet yield in the commonly targeted three-to-five-times-baseline range depends on protocol and hardware, never on the logo.

| Tube type | Typical contents | Certification question to ask |
|---|---|---|
| Plain citrate tube | 3.2% sodium citrate | Does the certificate cover re-injection, or diagnostics only? |
| Gel-separator tube | Citrate plus thixotropic separator gel | Is the gel configuration covered for blood returned to the patient? |
| Combination kit | Citrate with additives such as hyaluronic acid | Does the certificate name this exact configuration? |
| Closed-system kit | Integrated draw–spin–extract set | Which components sit under which certificate and class? |

Additives change the regulatory question because a substance contacting blood destined for the patient forms part of the intended purpose: a certificate issued for a plain tube does not stretch automatically to its gel or hyaluronic sibling marketed under the same brand. Documentation quality is where suppliers genuinely differ. Practitioner-facing platforms such as [Bind Pharma](https://bindpharma.com/prp) publish tube specifications and certification paperwork up front, which shortens verification considerably — but the checking obligation never transfers, and it ends with the clinic that injects.

## What the mark leaves to you

A valid certificate on CE marked PRP tubes answers the device question and no other. The first remaining layer is national law on blood handling: member states differ on whether autologous PRP prepared and used within a single procedure falls inside blood-establishment or medicinal-product rules, and the same tube can be routine in one jurisdiction and contentious next door. That question belongs, in writing, with your national regulator, and the answer belongs in the compliance file.

The second layer is claims. Certification says nothing about whether PRP regrows hair. That argument rests on a modest but real randomised trial base and on preparation quality, and the operational half is yours — spin protocol, timing and injection technique, covered in our [step-by-step PRP protocol](/articles/prp-protocol-for-hair-loss-step-by-step), with the comparative evidence weighed in [PRP versus mesotherapy](/articles/prp-vs-mesotherapy-for-hair-loss). The third layer is competence: no certificate examines the hands drawing, spinning and injecting, which is why the service-design questions in [building a PRP programme](/articles/building-a-prp-program-in-your-clinic) matter more to outcomes than anything printed on the box. Advertising codes add an adjacent layer of their own: a certified tube does not license the phrase "clinically proven" on a clinic website, and national advertising regulators police that language separately. A clinic that treats the tube as the treatment has the emphasis backwards.

## A purchasing protocol that survives inspection

The working protocol fits on a page. Before the first order: obtain the Declaration of Conformity, the notified body certificate and the current IFU; check the notified body number against NANDO; find the device in EUDAMED. At first use: record the lot number of every tube in the treatment record, so that each session traces to a batch. Annually, and on any product change: re-verify certificate validity and IFU version. Give the file a single named owner — usually the lead nurse or the clinic manager — so that renewal dates do not drift. UK-facing clinics add one further check: recognition arrangements between CE and UKCA marking have shifted repeatedly, so current status comes from the MHRA rather than from memory.

The payoff is inspection asymmetry. The clinic that produces a complete supplier file in five minutes has a short, boring inspection; the clinic emailing its distributor that afternoon has a different kind, and vigilance obligations do not wait for the reply. CE marked PRP tubes bought through this protocol are a consumable; tubes bought on a brochure claim are a liability wearing a logo.

## Sources and further reading

- Gentile P, Garcovich S, Bielli A, et al. [The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial](https://pubmed.ncbi.nlm.nih.gov/26400925/). *Stem Cells Translational Medicine*. 2015;4(11):1317–1323.
- Alves R, Grimalt R. [Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia](https://pubmed.ncbi.nlm.nih.gov/27035501/). *Dermatologic Surgery*. 2016;42(4):491–497.

## FAQ

**Q: Our tubes carry a CE mark with no four-digit number. Is that a problem?**

It means no notified body was involved — self-declared class I, or a general IVD. For a device whose output is re-injected, that is a red flag, because preparing an injectable generally sits beyond self-certification. Ask the manufacturer which MDR class and certificate cover the re-injection purpose, and verify the answer with the notified body named.

**Q: Can we legally use IVD-certified tubes to prepare PRP for injection?**

The certificate covers diagnostic blood collection, so re-injection is use outside the certified intended purpose. Enforcement varies by member state, but the liability position is consistent: the clinic assumes device-related risk the manufacturer never certified, and insurers read it the same way. Confirm the position with your national regulator before relying on such tubes.

**Q: What MDR class should a PRP tube intended for re-injection hold?**

Devices that modify blood for re-administration typically sit in class IIa or IIb, depending on mechanism and additives. The classification is fixed in the manufacturer's technical documentation and confirmed by the notified body, not by the distributor's brochure. Ask for the class in writing and check it against the certificate rather than accepting a verbal assurance.

**Q: How do we verify that a CE certificate is genuine and current?**

Match the four-digit notified body number on the certificate to that body's entry in the EU's NANDO database, check the certificate's expiry date, and search for the device in EUDAMED by manufacturer or Basic UDI-DI. Five minutes of checking covers the three commonest failures: invented numbers, expired certificates and certificates for a different product line.

**Q: Does a CE mark mean the PRP produced will be clinically effective?**

No. Certification addresses device safety and performance for the intended purpose, not therapeutic efficacy. The clinical case for PRP in androgenetic alopecia rests on a modest trial base and on your preparation protocol — spin parameters, platelet yield and injection technique — none of which the mark examines. Treat certification and evidence as separate purchasing questions.

**Q: Are FDA-cleared PRP kits automatically acceptable in Europe?**

No. FDA clearance and CE marking are separate frameworks with different classification logic, and neither transfers to the other's market. A kit cleared in the United States still needs MDR-compliant certification for Europe, with an intended purpose covering re-injection, and the reverse holds too. Where a kit is sold on both continents, request the EU documents specifically.

**Q: Do additives such as separator gel or hyaluronic acid change the certification?**

They can change the classification, the certificate scope and the questions the notified body asks, because an additive contacts blood that returns to the patient. A plain citrate tube and a combination kit are not regulatory equivalents, even when marketed side by side. Check that the certificate names the exact configuration you buy.

**Q: What should the supplier file contain before first clinical use?**

The Declaration of Conformity, the notified body certificate, the current IFU, a UDI or EUDAMED reference, and the distributor's contact for vigilance reporting — plus lot-number traceability linking each treatment session to a tube batch. Kept current annually, the file takes minutes per product and answers most inspection questions before they are asked.